Facilitators and barriers of medication adherence in pediatric liver and kidney transplant recipients: a

Anouck Claes1, Anneloes Decorte2, Elena Levtchenko2

  • 1University of Leuven, Leuven, Belgium.

Progress in Transplantation (Aliso Viejo, Calif.)
|December 10, 2014
PubMed

Insights

Pediatric transplant patients face medication adherence challenges. Practical aids and fewer regimen changes significantly improve adherence for young transplant recipients.

Area of Science:

  • Pediatric Transplant Medicine
  • Pharmacology
  • Patient Adherence Research

Background:

  • Young transplant patients (≤11 years) often struggle with adhering to immunosuppressive and co-medications.
  • Existing research on adherence determinants in this age group is limited, flawed, and often focuses narrowly on barriers.

Purpose of the Study:

  • To identify factors that positively and negatively affect medication adherence in pediatric transplant recipients.
  • To explore facilitators and barriers to medication adherence from parental perspectives.

Main Methods:

  • A consecutive mixed-methods design combining qualitative interviews and quantitative adherence assessment.
  • Semistructured interviews with parents of 10 pediatric liver or kidney transplant recipients (2-11 years old).
  • Adherence quantification and use of the "immunosuppressive medication adherence barriers" self-report instrument.

Main Results:

  • Common barriers included forgetfulness (70%), vomiting (70%), bad taste (60%), and routine interruptions (60%).
  • Key facilitators reported by parents were practical aids (100%), always carrying medication (100%), fewer medications (80%), and stable regimens (80%).
  • No significant distinction in barriers or facilitators was found between immunosuppressants and co-medications.

Conclusions:

  • Peer experiences offer valuable insights for improving medication adherence in young transplant patients.
  • Practical strategies and regimen simplification are crucial for enhancing adherence in this population.
Abstract

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
605
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
784
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
392
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
880
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
373
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
266